Condition: Coronary Microvascular Disease · Sponsor: Qilu Hospital of Shandong University
To investigate the efficacy and safety of Qishenyiqi in patients with microvascular angina pectoris. Long-term follow-up of 1 year will be performed to evaluate the effect of Qishenyiqi on coronary flow reserve and adverse cardiovascular events in patients with coronary microvascular disease.
This description comes directly from the study's public registry record.
Panpan Hao, Dr. · 8618560086593 · panda.how@sdu.edu.cn
Always discuss trial participation with your own doctor first.
| Qianfoshan Hospital, Shandong University | Jinan, Shandong, China | Active Not Recruiting |
| Qilu Hospital of Shandong University | Jinan, Shandong, China | Recruiting |
| Jinan Central Hospital Affiliated to Shandong First Medical University | Jinan, Shandong, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06699420